CRISPR/Cas9‐mediated introduction of the sodium/iodide symporter gene enables noninvasive in vivo tracking of induced pluripotent stem cell‐derived cardiomyocytes

Techniques that enable longitudinal tracking of cell fate after myocardial delivery are imperative for optimizing the efficacy of cell‐based cardiac therapies. However, these approaches have been underutilized in preclinical models and clinical trials, and there is considerable demand for site‐speci...

Descripción completa

Detalles Bibliográficos
Autores principales: Ostrominski, John W., Yada, Ravi Chandra, Sato, Noriko, Klein, Michael, Blinova, Ksenia, Patel, Dakshesh, Valadez, Racquel, Palisoc, Maryknoll, Pittaluga, Stefania, Peng, Kah‐Whye, San, Hong, Lin, Yongshun, Basuli, Falguni, Zhang, Xiang, Swenson, Rolf E., Haigney, Mark, Choyke, Peter L., Zou, Jizhong, Boehm, Manfred, Hong, So Gun, Dunbar, Cynthia E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Enabling Technologies for Cell‐based Clinical Translation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519772/
https://www.ncbi.nlm.nih.gov/pubmed/32700830
http://dx.doi.org/10.1002/sctm.20-0019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519772/
https://www.ncbi.nlm.nih.gov/pubmed/32700830
http://dx.doi.org/10.1002/sctm.20-0019

Ejemplares similares